vialaudit
The Roundup
igf-1 lr3 · oregon

Is IGF-1 LR3 legal in Oregon?

status · caveats apply
No FDA approval (distinct from mecasermin/Increlex); WADA S2.1 explicitly named IGF-1 analogue; NCAA explicitly banned. No state-level peptide restrictions beyond federal law in Oregon.

category: no approval · last verified May 13, 2026

§ 01

Quick answer

No FDA approval (distinct from mecasermin/Increlex); WADA S2.1 explicitly named IGF-1 analogue; NCAA explicitly banned. No state-level peptide restrictions beyond federal law in Oregon.
§ 02

Full status breakdown

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Not on Cat 2 explicitly; PCAC has not voted. Distinct from mecasermin/Increlex (NDA 021839, recombinant human IGF-1) — LR3 is a chemically distinct analog with 13-aa N-terminal extension and Arg substitution.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved analog of an approved drug. 'RUO' framing does not cure FDCA §505 violation where human use is foreseeable.
Personal possession: Not federally criminalized.

Oregon — state-specific

Sport-body status

WADA 2026
on prohibited list · class S2.1 · both
IGF-1 and IGF-1 analogues explicitly named under S2.1 (Erythropoietin-Receptor Agonists and Growth Factors).
USADA
NCAA

What we couldn’t verify

§ 03

Also known as

IGF-1 LR3 is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Long R3 IGF-1
  • IGF-1 Long R3
  • Insulin-like Growth Factor 1 Long R3
  • Long Arg3 IGF-1
  • LR3-IGF-1
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch